Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.85 USD 0.61% Market Closed
Market Cap: 484.3m USD
Have any thoughts about
Theravance Biopharma Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Theravance Biopharma Inc

Current Assets 116.5m
Cash & Short-Term Investments 91.4m
Receivables 16.8m
Other Current Assets 8.3m
Non-Current Assets 239.6m
PP&E 37.1m
Other Non-Current Assets 202.5m
Current Liabilities 23.4m
Accounts Payable 1.5m
Accrued Liabilities 15.5m
Other Current Liabilities 6.5m
Non-Current Liabilities 147m
Long-Term Debt 29.7m
Other Non-Current Liabilities 117.3m

Balance Sheet
Theravance Biopharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
89
113
345
89
378
58
82
90
298
102
Cash Equivalents
89
113
345
89
378
58
82
90
298
102
Short-Term Investments
165
60
156
260
127
223
212
84
29
63
Total Receivables
2
37
10
9
11
51
70
58
17
17
Accounts Receivables
2
37
10
9
11
12
16
14
17
17
Other Receivables
0
0
0
0
0
39
54
44
0
0
Inventory
13
10
12
17
0
0
0
0
0
0
Other Current Assets
6
18
6
4
17
7
31
19
9
14
Total Current Assets
275
238
529
379
533
339
393
250
354
134
PP&E Net
10
10
9
10
13
59
60
53
52
45
PP&E Gross
10
10
9
10
13
59
60
53
52
45
Accumulated Depreciation
55
42
44
47
50
48
46
39
33
22
Note Receivable
0
0
0
8
0
4
0
0
0
0
Long-Term Investments
51
51
100
42
12
5
13
68
0
0
Other Long-Term Assets
1
2
3
3
2
2
3
4
202
203
Total Assets
338
N/A
300
-11%
639
+113%
441
-31%
560
+27%
409
-27%
469
+15%
375
-20%
607
+62%
382
-37%
Liabilities
Accounts Payable
10
19
2
6
9
5
7
3
2
2
Accrued Liabilities
31
31
47
57
46
66
86
39
27
17
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
10
19
17
0
0
Other Current Liabilities
0
0
0
0
43
32
12
0
0
6
Total Current Liabilities
41
50
49
63
99
112
124
59
29
25
Long-Term Debt
0
0
223
224
454
445
600
599
0
28
Other Liabilities
7
8
17
40
59
76
49
55
137
116
Total Liabilities
48
N/A
57
+19%
289
+406%
326
+13%
612
+88%
633
+3%
773
+22%
713
-8%
166
-77%
169
+2%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
139
322
512
798
1 012
1 249
1 527
1 726
854
909
Additional Paid In Capital
429
565
863
914
961
1 025
1 223
1 388
1 296
1 122
Other Equity
0
0
0
1
0
0
0
0
0
0
Total Equity
290
N/A
243
-16%
350
+44%
115
-67%
52
N/A
224
-334%
304
-36%
339
-11%
442
N/A
213
-52%
Total Liabilities & Equity
338
N/A
300
-11%
639
+113%
441
-31%
560
+27%
409
-27%
469
+15%
375
-20%
607
+62%
382
-37%
Shares Outstanding
Common Shares Outstanding
32
38
53
54
56
57
64
74
65
48

See Also

Discover More